Paul E Verweij
Overview
Explore the profile of Paul E Verweij including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
360
Citations
12574
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Delma F, Yang D, Cabrera-Orefice A, Coolen J, Al-Hatmi A, Ahmed S, et al.
NPJ Antimicrob Resist
. 2025 Jan;
2(1):24.
PMID: 39843955
Cryptococcal meningitis is a high-mortality infection. Adding 5-fluorocytosine (5-FC) to its treatment improves outcomes, but resistance to 5-FC presents a significant challenge. We conducted whole-genome sequencing on seven C. neoformans...
2.
Lamberink H, Huygens S, Aerts R, Lagrou K, van Dijk K, Langerak D, et al.
J Clin Microbiol
. 2025 Jan;
63(2):e0105324.
PMID: 39835823
An accurate diagnosis of invasive aspergillosis (IA) in patients with underlying hematological malignancies relies heavily on galactomannan detection. In this study, we compared the VirCLIA chemiluminescence immunoassay (CLIA) with the...
3.
Izadi A, Dos Santos C, Mohamadi A, Tehupeiory-Kooreman M, Soleimani M, Aala F, et al.
Curr Eye Res
. 2024 Oct;
50(3):252-257.
PMID: 39466138
Purpose: Fungal keratitis (FK) is a difficult condition to treat, particularly in underdeveloped nations. The study aimed to compare the activity of chlorhexidine (CHX) and seven antifungal agents against a...
4.
Delma F, Melchers W, Verweij P, Buil J
JAC Antimicrob Resist
. 2024 Oct;
6(5):dlae153.
PMID: 39372819
Objectives: EUCAST has established clinical breakpoints and epidemiological cutoff values (ECOFFs) for spp. However, limited data are available for 5-flucytosine (5-FC). We assessed the susceptibility of 5-FC against a large...
5.
Spruijtenburg B, Meis J, Verweij P, de Groot T, Meijer E
Mycopathologia
. 2024 Aug;
189(5):72.
PMID: 39096450
Fungal infections pose an increasing threat to public health. New pathogens and changing epidemiology are a pronounced risk for nosocomial outbreaks. To investigate clonal transmission between patients and trace the...
6.
Buil J, Meijer E, den Reijer M, Zeeuwen-Franssen M, Melchers W, Verweij P
Ned Tijdschr Geneeskd
. 2024 Aug;
168.
PMID: 39087461
is a recently identified dermatophyte that frequently causes extensive and persistent dermatomycosis, particularly tinea corporis, tinea cruris, and tinea faciei. The infection is frequently encountered in countries of the Indian...
7.
Pinana J, Cesaro S, Mikulska M, Verweij P, Bergeron A, Neofytos D, et al.
Curr Res Transl Med
. 2024 Jul;
72(3):103461.
PMID: 39032263
In 2023, the EBMT Practice harmonization and Guidelines Committee partnered with the EBMT Infection Diseases Working Party (IDWP) to undertake the task of delivering best practice recommendations, aiming to harmonize...
8.
Feys S, Carvalho A, Clancy C, Gangneux J, Hoenigl M, Lagrou K, et al.
Lancet Respir Med
. 2024 Jul;
12(9):728-742.
PMID: 39025089
Influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA) are increasingly recognised as important complications in patients requiring intensive care for severe viral pneumonia. The diagnosis can typically be made...
9.
Ergun M, Jansen A, Hilbrands L, de Kort E, Kunst H, Reijers M, et al.
J Antimicrob Chemother
. 2024 Jun;
79(8):1801-1810.
PMID: 38935893
Background: Isavuconazole is a relatively new antifungal agent indicated for the management of various invasive fungal diseases (IFDs), including invasive aspergillosis. Information on real-world experience with isavuconazole is scarce. This...
10.
van Dijk M, Buil J, Tehupeiory-Kooreman M, Broekhuizen M, Broens E, Wagenaar J, et al.
Mycopathologia
. 2024 Jun;
189(4):50.
PMID: 38864903
Aspergillus fumigatus is a saprophytic fungal pathogen that causes opportunistic infections in animals and humans. Azole resistance has been reported globally in human A. fumigatus isolates, but the prevalence of...